Iontophoresis for corneal collagen crosslinking

Mark Daniell^{1

2

3}

Affiliations

¹ Department of Surgery, University of Melbourne, East Melbourne, Victoria, Australia.
² Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia.
³ Centre for Eye Research Australia, East Melbourne, Victoria, Australia.

Editorial

Mark Daniell. Clin Exp Ophthalmol. 2021 Apr.

. 2021 Apr;49(3):223-224.

doi: 10.1111/ceo.13921.

Mark Daniell^{1

2

3}

¹ Department of Surgery, University of Melbourne, East Melbourne, Victoria, Australia.
² Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia.
³ Centre for Eye Research Australia, East Melbourne, Victoria, Australia.

No abstract available

References

1. Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135:620-627.
1. Wittig-Silva C, Chan E, Islam FM, Wu T, Whiting M, Snibson GR. A randomized, controlled trial of corneal collagen cross-linking in progressive keratoconus: three-year results. Ophthalmology. 2014;121:812-821.
1. Hersh PS, Stulting RD, Muller D, Durrie DS, Rajpal RK. United States multicenter clinical trial of corneal collagen crosslinking for keratoconus treatment. Ophthalmology. 2017;124:1259-1270.
1. Lombardo M, Giannini D, Lombardo G, Serrao S. Randomized controlled trial comparing transepithelial corneal cross-linking using iontophoresis with the Dresden protocol in progressive keratoconus. Ophthalmology. 2017;124:804-812.
1. Bouheraoua N, Jouve L, Borderie V, Laroche L. Three different protocols of corneal collagen crosslinking in keratoconus: conventional, accelerated and iontophoresis. J Vis Exp. 2015;105:53119. https://doi.org/10.3791/53119.